Agreement with Medicines Australia on behalf of the innovative medicines sectorStrategic Agreement • May 9th, 2017
Contract Type FiledMay 9th, 2017This Agreement will deliver more certainty for the medicines industry through a stable PBS environment, where funding for new listings is further supported through delivering price reductions for on-patent medicines that are reaching the end of their patent life, and when these medicines come off patent and become subject to competition.
Agreement with Medicines Australia on behalf of the innovativeStrategic Agreement • May 9th, 2017
Contract Type FiledMay 9th, 2017This Agreement will deliver more certainty for the medicines industry through a stable PBS environment, where funding for new listings is further supported through delivering price reductions for on-patent medicines that are reaching the end of their patent life, and when these medicines come off patent and become subject to competition.
Agreement with Medicines Australia on behalf of the innovativeStrategic Agreement • May 9th, 2017
Contract Type FiledMay 9th, 2017This Agreement will deliver more certainty for the medicines industry through a stable PBS environment, where funding for new listings is further supported through delivering price reductions for on-patent medicines that are reaching the end of their patent life, and when these medicines come off patent and become subject to competition.